Person Dr Olivia Dean National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in Anti-inflammatory treatment of depression (funded by National Health and Medical Research Council) Participant in CREDIT: The CRE for the Development of Innovative Therapies for Psychiatric Disorders (funded by National Health and Medical Research Council) Principal investigator of Integrated exploration of novel therapies for depression (funded by National Health and Medical Research Council) Participant in The N-ICE trial: A randomised controlled trial of the safety and efficacy of N-Acetyl Cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence (funded by National Health and Medical Research Council) Principal investigator of The efficacy of adjunctive Garcinia mangostana Linn. pericarp for bipolar depression: A 24-week double-blind, randomized, placebo-controlled trial. (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in Anti-inflammatory treatment of depression (funded by National Health and Medical Research Council) Participant in CREDIT: The CRE for the Development of Innovative Therapies for Psychiatric Disorders (funded by National Health and Medical Research Council) Principal investigator of Integrated exploration of novel therapies for depression (funded by National Health and Medical Research Council) Participant in The N-ICE trial: A randomised controlled trial of the safety and efficacy of N-Acetyl Cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence (funded by National Health and Medical Research Council) Principal investigator of The efficacy of adjunctive Garcinia mangostana Linn. pericarp for bipolar depression: A 24-week double-blind, randomized, placebo-controlled trial. (funded by National Health and Medical Research Council) User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover